Public Release: 

BGI integrates QIAGEN Ingenuity Variant Analysis to its sequencing services

BGI Shenzhen

Shenzhen, China, and Redwood City, California, May 4, 2015 - BGI, the world's largest genomics organization, announced to expand relationship with QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) and to provide QIAGEN's Ingenuity® Variant Analysis™ in integrated bioinformatics for all customers of BGI's sequencing services.

Under the reseller agreement, BGI customers will receive sequencing data generated from their samples through Ingenuity Variant Analysis' secure, cloud-based environment and gain access to its leading comprehensive gene variant data and genomic interpretation applications. BGI will provide Ingenuity Variant Analysis to customers in China, Hong Kong and Taiwan, with plans to expand to other regions throughout the year. BGI collaborates with more than 10,000 organizations and 30,000 partners worldwide, providing sequencing services for thousands of research projects, including large-scale genome initiatives.

Yingrui Li, Chief Scientist of BGI, said: "We welcome this opportunity to expand our relationship with QIAGEN for the benefit of BGI collaborators around the world. Coupling BGI's world-class sequencing with the deep bioinformatics of Ingenuity Variant Analysis will give researchers an enhanced, integrated way to seamlessly move quickly from raw data to valuable insights."

"We are very pleased to expand QIAGEN's relationship with BGI, the global leader in sequencing services. Integrating Ingenuity Variant Analysis into BGI's highly reliable sequencing services will enable clients to accelerate workflows. They'll be able to transform large quantities of genomic data into valuable molecular insights for research or clinical applications," said Laura Furmanski, Head of QIAGEN's Bioinformatics Business Area. "Bioinformatics solutions from QIAGEN are growing rapidly as scientists and healthcare professionals increasingly use genomic information to guide research and provide precise diagnosis for medical decision-making. We are committed to working with leading organizations such as BGI to make these improvements in life possible."

###

About BGI

BGI, founded in 1999 with the vision of using genomics to benefit the human race, is now the world's largest genomics organization. Headquartered in Shenzhen, China, BGI encompasses both private nonprofit research institutes and commercial units for sequencing applications, as well as its affiliated offshoots BGI Americas and BGI Europe. BGI has established partnerships and collaborations with leading academic and government research institutions around the world, as well as global biotechnology and pharmaceutical companies, to support a variety of healthcare, agricultural, environmental and related applications. BGI's sequencing services are powered by more than 230 DNA sequencers with a data output capability of approximately 16 terabytes per day. For more information, please visit http://www.genomics.cn.

About QIAGEN

QIAGEN N.V., a Netherlands-based holding company, is the leading global provider of Sample to Insight solutions to transform biological materials into valuable molecular insights. QIAGEN sample technologies isolate and process DNA, RNA and proteins from blood, tissue and other materials. Assay technologies make these biomolecules visible and ready for analysis. Bioinformatics software and knowledge bases interpret data to report relevant, actionable insights. Automation solutions tie these together in seamless and cost-effective molecular testing workflows. QIAGEN provides these workflows to more than 500,000 customers around the world in Molecular Diagnostics (human healthcare), Applied Testing (forensics, veterinary testing and food safety), Pharma (pharmaceutical and biotechnology companies) and Academia (life sciences research). As of December 31, 2014, QIAGEN employed approximately 4,300 people in over 35 locations worldwide. Further information can be found at http://www.qiagen.com.

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.